Newton, MA-based biotech firm Clinical Data (NASDAQ:[[ticker:CLDA]]) said today that it has inked a deal to raise some $25 million in a private placement of stock and warrants. The agreement, with affiliates of Clinical Data board chair Randal J. Kirk, includes some 1.5 million newly issued shares of common stock and warrants on another 757,000 shares.
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
View all posts by Rebecca Zacks
